CARIS LIFE SCIENCES, INC. Earnings Per Share (Diluted)
CARIS LIFE SCIENCES, INC. (CAI) reported Earnings Per Share (Diluted) of $0.00 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $0.00.
- CARIS LIFE SCIENCES, INC. earnings per share, diluted for the quarter ending 2026-03-31 was $0.00.
- CARIS LIFE SCIENCES, INC. earnings per share, diluted for the quarter ending 2025-12-31 was $0.29.
- CARIS LIFE SCIENCES, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $0.08.
- CARIS LIFE SCIENCES, INC. earnings per share, diluted for fiscal 2025 was -$3.22.
- CARIS LIFE SCIENCES, INC. earnings per share, diluted for fiscal 2024 was -$10.66.
- CARIS LIFE SCIENCES, INC. earnings per share, diluted for fiscal 2023 was -$13.24.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.29 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.37 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.29 derived: net income ÷ weighted average shares · filed 2026-05-08 | $0.37 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $0.29 derived: net income ÷ weighted average shares · filed 2026-03-03 | $0.37 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$1.91 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$3.22 10-K · filed 2026-03-03 |
| 2025-09-30 | $0.08 10-Q · filed 2025-11-05 | -$2.72 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$4.83 10-Q · filed 2025-11-05 | -$6.29 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$7.97 10-Q · filed 2026-08-05 | -$12.80 10-Q · filed 2026-08-05 | -$15.55 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$18.59 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$3.57 10-Q · filed 2026-05-08 | -$5.30 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$7.89 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$10.43 derived: net income ÷ weighted average shares · filed 2026-05-08 |
| 2024-12-31 | -$1.74 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$4.33 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$6.87 derived: net income ÷ weighted average shares · filed 2026-03-03 | -$10.66 10-K · filed 2026-03-03 |
| 2024-09-30 | -$2.59 10-Q · filed 2025-11-05 | -$5.13 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$8.92 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$2.54 10-Q · filed 2025-08-12 | -$6.34 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | -$13.24 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |